An extraordinary effort will be needed to sustain confidence in vaccines, given the unprecedented level of misinformation being propagated about them, even from official sources, writes Heidi J. Larson, Director of the Vaccine Confidence Project.
This series of studies highlights the importance of adopting constructive approaches to restoring public health confidence in vaccination, particularly mRNA vaccines.
The objective of this systematic review was to examine documented uses and evidence on the effectiveness of conversational AI for vaccine communication.
Ben Plumley, Managing Director of our sister organisation the Global Listening Project, checks in with Professors’ Heidi Larson and Leesa Lin as they share the first top-line results from the Project’s 70-country societal preparedness index
Heidi Larson, Director of the Vaccine Confidence Project and Professor of Anthropology, Risk and Decision Science and researcher Sara…
This multisite research was designed to harness the power of social media to increase vaccination confidence and uptake in Thailand, Hong Kong, Singapore, and Japan.
This research aims to develop and evaluate a suite of feasible interventions based on artificial intelligence technologies checking extensions, real-time dashboards, and chatbots – that improve the ability to debunk misinformation, boost self-efficacy in the vaccination decision-making process.
This research applies communication and behavioural theories to comprehensively assess confidence in and acceptance of HPV vaccines in Japan, Korea, and China amongst people who have not received the vaccine, in order to develop effective digital communication strategies to increase uptake.
Japan has one of the highest vaccine hesitancy rates in the world. However, few studies have assessed how mobile messenger apps affect COVID-19 vaccine hesitancy. This study used a cross-sectional survey to assess the impact of text messages from Corowa-kun – a free chatbot – on COVID-19 vaccine hesitancy amongst users.
This report uses VCP data from 2015 – May 2021 to assess local barriers and drivers to adult vaccine uptake in Low – Middle Income Countries, with a view to supporting the development of targeted interventions and programs.
EBODAC (Ebola Vaccine Deployment, Acceptance and Compliance) was set up to develop strategies and tools to encourage acceptance and uptake of new Ebola vaccines in the context of clinical trials.
In 2019, the EBODAC team developed and piloted the 3C Gap Analysis Tool to help establish a countries readiness for Ebola vaccine deployment in non-emergency…